DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

AstraZeneca Updates on PLATO Study Investigation on Brilinta - Analyst Blog

Lannett Updates on Digoxin Safety Issues, Expands Portfolio - Analyst Blog

3 Reasons Bristol-Myers Squibb's Stock Could Rise

Bristol-Myers Squibb is on the cusp of moving into the next phase of its life cycle. Will this transformation propel shares higher?

GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog

GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog

Actavis Up on Positive Phase III Ceftazidime-Avibactam Data - Analyst Blog

Nektar Therapeutics Has More To Give

Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

European ADRs Up as Pharma Companies, Select Banks Gain

Why AstraZeneca (AZN) Stock Is Higher Today

Pre-Market Activity Shows Gains For AstraZeneca (AZN)

See More Articles...